Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities. | J Biomed Sci | 2023 | 36627707 | PubTator, text mining | PubMed |
| Kinome-wide screening uncovers a role for Bromodomain Protein 3 in DNA double-stranded break repair. | DNA Repair (Amst) | 2023 | 36608404 | PubTator, text mining | PubMed |
| Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach. | ACS Chem Biol | 2023 | 36606710 | PubTator, text mining | PubMed |
| BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells. | J Exp Clin Cancer Res | 2023 | 36604676 | PubTator, text mining | PubMed |
| Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment. | Adv Sci (Weinh) | 2023 | 36599655 | PubTator, text mining | PubMed |
| Targeted degradation via direct 26S proteasome recruitment. | Nat Chem Biol | 2023 | 36577875 | PubTator, text mining | PubMed |
| Physachenolide C is a Potent, Selective BET Inhibitor. | J Med Chem | 2023 | 36577036 | PubTator, text mining | PubMed |
| Targeted protein degradation as an antiviral approach. | Antiviral Res | 2023 | 36567024 | PubTator, text mining | PubMed |
| Crystal structure of the OrfX1-OrfX3 complex from the PMP1 neurotoxin gene cluster. | FEBS Lett | 2023 | 36403098 | PubTator, text mining | PubMed |
| BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation. | Mol Cancer Res | 2023 | 36378541 | PubTator, text mining | PubMed |
| A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies. | Clin Cancer Res | 2023 | 36350312 | PubTator, text mining | PubMed |
Overexpression of Bromodomain and Extraterminal Domain is Associated with Progression, Metastasis and Unfavorable Outcomes: Highlighting Prognostic and Therapeutic Value of the BET Protein Family in Gastric Cancer. | Anticancer Agents Med Chem | 2023 | 36284375 | PubTator, text mining | PubMed |
| Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma. | Cancer Res Treat | 2023 | 36265509 | PubTator, text mining | PubMed |
| Sex-Specific Genetic and Transcriptomic Liability to Neuroticism. | Biol Psychiatry | 2023 | 36244801 | PubTator, text mining | PubMed |
| ΔNp63α in cancer: importance and therapeutic opportunities. | Trends Cell Biol | 2023 | 36115734 | PubTator, text mining | PubMed |
| Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9). | Pigment Cell Melanoma Res | 2023 | 36112085 | PubTator, text mining | PubMed |
| Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives. | Blood Rev | 2023 | 35989139 | PubTator, text mining | PubMed |
| The contemporary management of cancers of the sinonasal tract in adults. | CA Cancer J Clin | 2023 | 35916666 | PubTator, text mining | PubMed |
| Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic. | Biochemistry | 2023 | 35856839 | PubTator, text mining | PubMed |
| Emerging roles of BET proteins in transcription and co-transcriptional RNA processing. | Wiley Interdiscip Rev RNA | 2023 | 35491403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=17